These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 2446703

  • 1. Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra.
    Oblin A, Zivkovic B, Bartholini G.
    Brain Res; 1987 Sep 22; 421(1-2):387-90. PubMed ID: 2446703
    [Abstract] [Full Text] [Related]

  • 2. Opposite responses in the striato-nigral substance P system to D1 and D2 receptor activation.
    Sonsalla PK, Gibb JW, Hanson GR.
    Eur J Pharmacol; 1984 Oct 01; 105(1-2):185-7. PubMed ID: 6208043
    [Abstract] [Full Text] [Related]

  • 3. Tachykinins in the rat substantia nigra: effects of selective dopamine receptor antagonists.
    Oblin A, Zivkovic B.
    Fundam Clin Pharmacol; 1991 Oct 01; 5(2):129-38. PubMed ID: 1712746
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O, Mohringe B, Fowler CJ.
    J Neural Transm; 1987 Oct 01; 69(3-4):163-77. PubMed ID: 2957465
    [Abstract] [Full Text] [Related]

  • 5. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
    Sivam SP.
    Brain Res; 1989 Oct 23; 500(1-2):119-30. PubMed ID: 2481560
    [Abstract] [Full Text] [Related]

  • 6. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
    Mela F, Marti M, Bido S, Cenci MA, Morari M.
    Neurobiol Dis; 2012 Jan 23; 45(1):573-82. PubMed ID: 22001605
    [Abstract] [Full Text] [Related]

  • 7. Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission.
    Zivkovic B, Oblin A, Bartholini G.
    Eur J Pharmacol; 1985 Jun 07; 112(2):253-5. PubMed ID: 2411575
    [Abstract] [Full Text] [Related]

  • 8. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
    Letter AA, Matsuda LA, Merchant KM, Gibb JW, Hanson GR.
    Brain Res; 1987 Sep 29; 422(1):200-3. PubMed ID: 3119151
    [Abstract] [Full Text] [Related]

  • 9. Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat.
    Floran B, Aceves J, Sierra A, Martinez-Fong D.
    Neurosci Lett; 1990 Aug 14; 116(1-2):136-40. PubMed ID: 2147981
    [Abstract] [Full Text] [Related]

  • 10. Quantitative radioimmunocytochemical evidence that haloperidol and SCH 23390 induce opposite changes in substance P levels of rat substantia nigra.
    Cruz CJ, Beckstead RM.
    Brain Res; 1988 Aug 02; 457(1):29-43. PubMed ID: 2458801
    [Abstract] [Full Text] [Related]

  • 11. In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum--II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen.
    Girault JA, Spampinato U, Glowinski J, Besson MJ.
    Neuroscience; 1986 Dec 02; 19(4):1109-17. PubMed ID: 2950336
    [Abstract] [Full Text] [Related]

  • 12. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
    McGonigle P, Boyson SJ, Reuter S, Molinoff PB.
    Synapse; 1989 Dec 02; 3(1):74-82. PubMed ID: 2521960
    [Abstract] [Full Text] [Related]

  • 13. Chronic treatment with SCH 23390 increases the production rate of dopamine D1 receptors in the nigro-striatal system of the rat.
    Giorgi O, Pibiri MG, Loi R, Corda MG.
    Eur J Pharmacol; 1993 Apr 15; 245(2):139-45. PubMed ID: 8098282
    [Abstract] [Full Text] [Related]

  • 14. 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine.
    Porceddu ML, Giorgi O, Ongini E, Mele S, Biggio G.
    Life Sci; 1986 Jul 28; 39(4):321-8. PubMed ID: 3526066
    [Abstract] [Full Text] [Related]

  • 15. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE, Crosby G, Iorio LC, Chipkin RE.
    Eur J Pharmacol; 1992 Feb 11; 211(2):169-76. PubMed ID: 1535318
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of chronic haloperidol and sulpiride treatment on nigral and striatal GABA content.
    Nicoletti F, Patti F, Condorelli DF, Rampello L, Giammona G, Di Giorgio RM, Canonico PL, Scapagnini U.
    J Neurochem; 1981 Oct 11; 37(4):1048-51. PubMed ID: 7320718
    [Abstract] [Full Text] [Related]

  • 17. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.
    Porceddu ML, Giorgi O, De Montis G, Mele S, Cocco L, Ongini E, Biggio G.
    Life Sci; 1987 Aug 10; 41(6):697-706. PubMed ID: 2956472
    [Abstract] [Full Text] [Related]

  • 18. Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra.
    Dawson TM, Dawson VL, Gage FH, Fisher LJ, Hunt MA, Wamsley JK.
    Exp Neurol; 1991 Mar 10; 111(3):282-92. PubMed ID: 1825638
    [Abstract] [Full Text] [Related]

  • 19. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1995 Oct 10; 275(1):237-44. PubMed ID: 7562556
    [Abstract] [Full Text] [Related]

  • 20. Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis.
    Thorré K, Sarre S, Smolders I, Ebinger G, Michotte Y.
    Brain Res; 1998 Jun 15; 796(1-2):107-16. PubMed ID: 9689460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.